Paul J. Williams

Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol)

Alex Sparreboom, Charity D. Scripture, Vuong Trieu et al. · Clinical Cancer Research · 2005 · 496 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

A Bone-Seeking Clone Exhibits Different Biological Properties from the MDA-MB-231 Parental Human Breast Cancer Cells and a Brain-Seeking Clone In Vivo and In Vitro

Toshiyuki Yoneda, Paul J. Williams, Toru Hiraga et al. · Journal of Bone and Mineral Research · 2001 · 481 citations · Full text

Medicine, Cancer Biology, Oncology +14

Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

Toshiyuki Yoneda, Akira Sasaki, Colin R. Dunstan et al. · Journal of Clinical Investigation · 1997 · 249 citations · Full text

Medicine, Oncology, Pharmacology +17

NADPH Oxidase 4 Induces Cardiac Fibrosis and Hypertrophy Through Activating Akt/mTOR and NFκB Signaling Pathways

Qingwei Zhao, Suryavathi Viswanadhapalli, Paul J. Williams et al. · Circulation · 2015 · 242 citations · Full text

Life Sciences, Cardiology, Molecular Biology +17

The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.

Toru Hiraga, Paul J. Williams, Gregory R. Mundy et al. · PubMed · 2001 · 241 citations

Medicine, Oncology, Pharmacology +17